论文部分内容阅读
目的观察参芪扶正联合放化疗治疗鼻咽癌疗效及不良反应。方法将30例在辽油二院住院鼻咽癌患者,随机分为实验组和对照组。实验组采用放化疗+参芪扶正。对照组为放化疗。两组放化疗剂量相似、条件相同,比较两组鼻咽癌患者在放化疗期间不良反应和对放化疗耐受性。结果实验组较对照组的疗效、生存质量均明显提高,不良反应明显减少。结论实验组明显改善了患者生存质量,减轻了化疗的不良反应,值得在临床治疗中推广应用。
Objective To observe the efficacy and adverse reactions of Shenqi Fuzheng combined with radiotherapy and chemotherapy in the treatment of nasopharyngeal carcinoma. Methods Thirty patients with nasopharyngeal carcinoma hospitalized in Liao You No.2 Hospital were randomly divided into experimental group and control group. Experimental group radiotherapy and chemotherapy + Shenqi Fuzheng. The control group was radiotherapy and chemotherapy. The two groups of radiotherapy and chemotherapy dose were similar, the same conditions, the two groups of patients with nasopharyngeal carcinoma during radiotherapy and chemotherapy adverse reactions and chemoradiation tolerance. Results Compared with the control group, the curative effect and quality of life in the experimental group were significantly improved and the adverse reaction was significantly reduced. Conclusion The experimental group significantly improved the quality of life of patients and reduced the adverse reactions of chemotherapy, which is worth popularizing and applying in clinical treatment.